Enzon Pharmaceuticals Inc. (ENZN)


Other OTC - Other OTC Delayed Price. Currency in USD
0.370.00 (0.00%)
At close: 3:55 PM EDT
People also watch:
QLTIALKSPDLIIMMUMYGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.37
Prev Close0.37
Bid0.00 x
Ask0.00 x
Day's Range0.37 - 0.38
52wk Range0.37 - 1.10
1y Target EstN/A
Market Cap16.27M
P/E Ratio (ttm)1.24
Beta0.82
Volume98,073
Avg Vol (3m)89,925
Dividend & Yield0.00 (0.00%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
    Capital Cube2 months ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016

    Categories: Yahoo Finance Click here to see latest analysis Enzon Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Enanta Pharmaceuticals, Inc., Amgen Inc., Merck & Co., Inc., XOMA Corporation, Bristol-Myers Squibb Company, Pfizer Inc., Vertex Pharmaceuticals Incorporated and ... Read more (Read more...)

  • PR Newswire2 months ago

    OTC Markets Group Welcomes Enzon Pharmaceuticals, Inc. to OTCQX

    NEW YORK, Aug. 9, 2016 /PRNewswire/ --   OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Enzon Pharmaceuticals, Inc. (OTCQX: ENZN), ...

  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016
    Capital Cube4 months ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016

    Click here to see latest analysisEnzon Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Enanta Pharmaceuticals, Inc., Amgen Inc., Merck & Co., Inc., XOMA Corporation, Bristol-Myers Squibb Company, Pfizer Inc., SciClone Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated […] (Read more...) The post Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 appeared first on CapitalCube.